Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Assessing the Efficacy of Laser Trabeculoplasty on Trabecular Stents in Open Angle Glaucoma
Author Affiliations & Notes
  • Jason Dossantos
    The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Alex T Pham
    The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Shriya Jain
    Johns Hopkins University, Baltimore, Maryland, United States
  • Brandon Bonilla
    The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Tara Srinivas
    The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Jella An
    Johns Hopkins Medicine Wilmer Eye Institute, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Jason Dossantos None; Alex Pham None; Shriya Jain None; Brandon Bonilla None; Tara Srinivas None; Jella An Alcon, Sight Sciences, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1920. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jason Dossantos, Alex T Pham, Shriya Jain, Brandon Bonilla, Tara Srinivas, Jella An; Assessing the Efficacy of Laser Trabeculoplasty on Trabecular Stents in Open Angle Glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1920.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : While the outcomes of trabecular stents (TS) post-Selective Laser Trabeculoplasty (SLT) are still debated, no research has addressed the outcomes of TS following Argon Laser Trabeculoplasty (ALT).1-3 This study evaluates the impact of Laser Trabeculoplasty (LTP) on outcomes of TS with phacoemulsification in open angle glaucoma patients.

Methods : A retrospective analysis was performed on glaucoma patients who had iStent or Hydrus microstent with cataract surgery, grouped by laser-naive or prior LTP (SLT or ALT). Eyes with any other prior glaucoma procedures were excluded and both successful and unsuccessful LTP were included. LTP success meant achieving target intraocular pressure (IOP) at 2 months post-laser without additional medication. The primary outcome was surgical success, defined as attaining the target IOP at 12-month without additional medication or glaucoma procedure, including repeat LTP. Eyes were matched (1:3) based on age, race, sex, glaucoma type and severity, baseline IOP and number of medications. Statistical analysis included ANOVA, chi-squared, and regression modeling.

Results : In our 220-eye cohort, 163 were laser-naive and 57 had prior LTP (35 SLT, 25 ALT). The SLT group had more preoperative medications than the laser-naïve or ALT group (p<0.05). One-year mean IOP reductions post-TS were 2.50 mmHg ± 5.1 (9.78% reduction; p<0.05) for laser-naïve, 2.69 mmHg ± 7.69 (8.91% reduction; p>0.05) for SLT, and 3.73 mmHg ± 5.40 (15.8% reduction; p<0.05) (p > 0.05 between groups). Mean medications at one year were 1.02 ± 1.23 (39.9% reduction; p<0.05) for laser-naïve, 1.57 ± 1.38 (35.5% reduction; p<0.05) for SLT, and 1.14 ± 1.32 (15.5% reduction; p>0.05) for ALT (P < 0.05 for laser-naïve vs ALT). Regression showed prior ALT (OR 1.27, p>0.05) or SLT (OR 0.733, p>0.05) did not impact TS surgery success, irrespective of LTP success or failure.

Conclusions : Prior LTP, including SLT and ALT, does not adversely affect the outcomes of TS with phacoemulsification in open angle glaucoma patients. While our results indicate a non-harmful relationship between LTP and TS, the retrospective design and limited number of cases warrant further research.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×